Clinical trial
A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Acthar Gel in Subjects With Persistently Active Systemic Lupus Erythematosus Despite Moderate Dose Corticosteroids
NCT02953821 is registered in ClinicalTrials.gov with Mallinckrodt as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Randomized, Double Blind, Placebo Controlled Study to Assess the Efficacy and Safety of Acthar Gel in Subjects With Persistently Active Systemic Lupus Erythematosus Despite Moderate Dose Corticosteroids
- Lead sponsor
- Mallinckrodt
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 16, 2016
- Completion date
- October 25, 2019
- Enrollment
- 172 (actual)
- Sites
- 39
Conditions
As the registry lists them; a condition with its own page is linked.